Jiangsu Hengrui Medicine (600276.SS) Profit Margin
Market Cap: $293.53B
Avg Volume: 35.56M
Industry: Drug Manufacturers - General
Sector: Healthcare
Profit Margin Summary (Annual)
According to Jiangsu Hengrui Medicine 's latest annual financial reports, the company has an operating profit margin of 21.52%. This metric indicates the percentage of revenue that remains after deducting operating expenses, excluding interest and taxes.
The company's gross profit margin stands at 84.55%, reflecting the percentage of revenue that exceeds the cost of goods sold (COGS).
The pretax profit margin is 20.45%, indicating the percentage of revenue that remains after deducting all expenses except taxes.
Lastly, the net profit margin is 18.85%, which shows the percentage of revenue that remains as profit after all expenses, including taxes, have been deducted.
The trailing twelve months (TTM) operating profit margin is 23.07%, providing a more up-to-date view of the company's financial health.
Operating Margin
21.52%
Gross Margin
84.55%
Pretax Margin
20.45%
Net Margin
18.85%
Historical Operating Profit Margin
Historical Gross Profit Margin
Historical Pretax Profit Margin
Historical Net Profit Margin
Jiangsu Hengrui Medicine Historical Profit Margins
Jiangsu Hengrui Medicine Profit Margin History
The table below shows the margins for each year, with the latest data available for the last fiscal year 2023.
| Year | Operating Margin | Gross Margin | Pretax Margin | Net Margin |
|---|---|---|---|---|
| 2023 | 21.52% | 84.55% | 20.45% | 18.85% |
| 2022 | 19.33% | 83.61% | 18.65% | 18.36% |
| 2021 | 18.01% | 85.56% | 17.24% | 17.49% |
| 2020 | 25.26% | 87.93% | 24.86% | 22.82% |
| 2019 | 26.41% | 87.49% | 26.00% | 22.88% |
| 2018 | 26.39% | 86.60% | 25.83% | 23.34% |
| 2017 | 27.52% | 86.63% | 27.17% | 23.25% |
| 2016 | 27.26% | 87.07% | 27.16% | 23.34% |
| 2015 | 27.47% | 85.28% | 27.50% | 23.31% |
| 2014 | 23.78% | 82.38% | 24.15% | 20.34% |
Related Metrics
Explore detailed financial metrics and analysis for 600276.SS.